The COS-AECOPD @EuroRespSoc Task Force is developing a core outcome set (COS) for #COPD exacerbation management.
|5 outcomes for use in phase 3 and phase 4 clinical drug trials in moderate-to-severe asthma|
|severe asthma exacerbation|
|change in asthma control|
|asthma-specific or severe asthma-specific quality of life|
|asthma-specific hospital stay (i.e. >24 hour stays at any level of care) or admission|
|asthma-specific emergency department visit|
Kidney & Transplant
Since 2017 Cochrane Kidney & Transplant has adopted the standardised core outcomes for HD & Tx into their protocols and reviews.
|Peritoneal dialysis (SONG-PD)|
|Children and adolescents (SONG-Kids)|
See page 16 for the core outcomes and other tiered outcomes.
One area that is very well developed COS eczema, developed at the Centre of Evidence Based Dermatology where Cochrane Skin are based.
4 core outcome domains
|Outcome domains||Validated instruments|